Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Primary Sjogren's Syndrome · Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Tongji Hospital of Tongji University, Shanghai, Shanghai Municipality, China